Tag:
TMC435
Latest Headlines
Latest Headlines
J&J and Bristol-Myers ally on another potential hep C blockbuster
The two research powerhouses will conduct a drug-drug interaction study.
Medivir deals generics biz amid HepC drug trials
Eyeing the prospects of its experimental hepatitis C drug, Swedish biotech Medivir ( $MVIR ) has sold off the generics unit of its subsidiary BioPhausia to Bluefish Pharmaceuticals. Medivir scooped up
